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Table 1 – Phenotypic characterization of Klebsiella
pneumoniae and Escherichia coli transformant carrying
blaGES-5.
MIC (g/mL)a
Isolate
(85PRO)
Transformant
E. coli carrying
blaGES-5
E. coli
TOP10
Antimicrobials
IMP ≥32 1.5 0.25
MEM ≥32 0.38 0.032
ERT ≥32 0.19 0.008
DOR ≥32 0.38 0.023
PTZ ≥256 ≥256 3
FEP 48 0.125 0.047
ATM 16 0.125 0.0125
SAM ≥256 ≥256 NP
GEN 12 6 NP
AMK 2 3 NP
PMB 0.5 0.25 NP
CST 0.38 0.125 NP
TGC 0.38 0.125 NP
Phenotypic screening
MHT  Weak positive Negative
APB Positive Negative
IPM, imipenem; MEM, meropenem; ERT, ertapenem; DOR,
doripenem; SAM, ampicillin-sulbactam; TZP, piperacillin-
tazobactam; FEP, cefepime; ATM, aztreonam; GEN, gentamicin;
AMK, amikacin; PMB, polymyxin B; CST, colistin; TGC, tigecyclin;
MHT, Modiﬁed Hodge Test; APB, combined-disk with phenylneumoniae in Southern  Brazil
ear Editor,
ES-type enzymes belong to Ambler Class A plasmid-
ncoded -lactamases. Although GES enzymes usually exhibit
xtended-spectrum -lactamases (ESBL) properties, changes
n  its active site enhance its activity conferring the ability
o  hydrolyze carbapenems.1 GES-type carbapenemases (GES-
,  GES-4, GES-5, GES-8, GES-11, GES-18, GES-20) have already
een  described in several countries.2 Although it has been
eported  in a Klebsiella pneumoniae from Brazil in 2010, in a
atient  admitted in 2008,3 no other isolate has ever since
een  reported in this country. Here, we  described another
arbapenem-resistant K. pneumoniae (CRKP) isolate carrying
he  blaGES-5 gene in Brazil.
The CRKP, identiﬁed by VITEK2 system (bioMeriéux,
rance), was  recovered from the blood of an adult
atient admitted to a university hospital in Porto Alegre,
razil,  in 2011. The patient had acute myeloid leukemia
ith recent exposure to many  antibiotics including
iperacillin–tazobactam, polymyxin B, meropenem, van-
omycin,  and cefepime. Despite treatment with polymyxin
 and tigecycline, the patient ultimately died six days after
RKP  recovering.
Minimum inhibitory concentrations (MICs), performed by
test®, and the phenotypic tests for carbapenemases detec-
ion  are shown in Table 1. The presence of blaGES was
emonstrated by multiplex real-time PCR that also included
laKPC, blaVIM, blaNDM, blaOXA-48 and blaIMP genes.4 Sequencing
f blaGES gene was  performed using the primers previously
escribed.5 GenBank was  used to access the GES sequences
eposited to date and BioEdit program was  used to compare
he  similarity between sequences, and revealed the presence
f  a GES-5. Plasmidial DNA from CRKP was  obtained from alka-
ine  lysis and it was  electroporated into an Escherichia coli Top10
Invitrogen).  Transformants were  selected on Luria-Bertani
gar containing 0.5 g/mL of ceftazidime. The plasmid elec-
roporation resulted in transformants, which conﬁrmed the
resence  of blaGES by PCR (Table 1).We  reported the second case of a CRKP carrying the blaGES-5
ene in Brazil. Although the ﬁrst GES-5-producing CRKP was
eported  in São Paulo in 2008,3 there has been no other report
f  this enzyme in Enterobacteriaceae since then in Brazil.boronic acid; NP. Not perfprmed.
a Assessed by Etest.
Unlike the other class A carbapenemase, KPC, widespread dis-
semination of GES-carbapenemase-producing isolates in this
country has not occurred. Nevertheless, it must be noted that
screening  for carbapenemases other than KPC has not been
routinely  performed in most laboratories in Brazil. Although
the  prevalence is likely low, especially if compared to KPC-
2,  the real prevalence of GES-5-producing isolates could be
underestimated.
Similar  to the GES-5 CRKP isolate from São Paulo, the MICs
of  carbapenems in the transformant dramatically declined to
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susceptibility levels for meropenem and doripenem, but to
1.5  g/mL to imipenem, indicating that other mechanisms,
such as those demonstrated in the São Paulo isolate (loss or
modiﬁcations  in porin),3 are critical to the high level resistance
to  carbapenems. Unfortunately, we  have not investigated
porins in our isolate. Additionally, we  have neither investi-
gated  the genetic environment of blaGES-5 nor the presence
of  other resistance genes. Of note, the transformant showed
low-level  resistance to gentamycin, possibly indicating the
presence  of an aminoglycoside modifying enzyme.
Also of note, modiﬁed Hodge test resulted in a weak
positive, making its interpretation difﬁcult; in contrast, the
combined-disks assay with boronic acid was  positive as
expected  for a Class A carbapenemase-producing isolates.
Surprisingly, however, boronic acid test was  negative in the
transformant. These ﬁndings warrant further investigation.
In  summary, we  report a second CRKP carrying the blaGES-5
gene, recovered in another Brazilian region. Although the
prevalence  of this enzyme is likely to be rare among Enterobac-
teriaceae  isolates from Brazil, properly powered surveillance
studies fully representative of all Brazilian regions are neces-
sary  to determine its real prevalence in our country.
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